Zhen Wenyao, Hu Wenxue, Dong Liang, An Shangjie, Jiang Xiue
State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun 130022 Jilin China
University of Science and Technology of China Hefei 230026 Anhui China.
Nanoscale Adv. 2020 Feb 10;2(4):1395-1409. doi: 10.1039/c9na00816k. eCollection 2020 Apr 15.
Cancer has become one of the primary threats to human beings, and traditional therapies (including surgery, chemotherapy and radiotherapy) show limited therapeutic efficacy due to the complexity of tumor biology. Furthermore, determining how to utilize the differences between the tumor microenvironment (TME) and healthy tissues and exploring new nanoplatforms that can realize early diagnosis and effective and non-toxic therapy are challenges in cancer theranostics. Numerous researchers have designed multifunctional nanomaterials and investigated their personalized therapy and regulation abilities toward TME, including oxygen generation, glutathione consumption and the production of reactive oxygen species and multi-model imaging effects. This review will introduce the latest progress in the design of multi-functional nanomedicines for the regulation of TME and their theranostics, and it will provide a critical angle for the future development of nanomedicine.
癌症已成为人类面临的主要威胁之一,由于肿瘤生物学的复杂性,传统疗法(包括手术、化疗和放疗)的治疗效果有限。此外,确定如何利用肿瘤微环境(TME)与健康组织之间的差异,并探索能够实现早期诊断以及有效且无毒治疗的新型纳米平台,是癌症诊疗领域面临的挑战。众多研究人员已设计出多功能纳米材料,并研究了它们对TME的个性化治疗和调控能力,包括产氧、谷胱甘肽消耗、活性氧生成以及多模态成像效果。本综述将介绍用于调控TME的多功能纳米药物设计及其诊疗方面的最新进展,并为纳米医学的未来发展提供一个批判性视角。